Disclosure of Payments from Drug Makers to Doctors Delayed

Only two drug makers at most are expected to disclose their annual payments to medical institutions and patient groups this month under the industry’s transparency guidelines, despite the market’s expectation that at least 10 or so companies would do so,...read more